Tag: Immunotherapy
Early Immunologic Biomarker Predicts Renal Allograft Outcomes
Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year
Fecal Transplant May Counter Anti-PD-1 Resistance in Melanoma
FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma
SARS-CoV-2 Infection Rate Low in Patients Receiving Antitumor Therapy
Less than 1 percent of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19
Maintenance Peanut Oral Immunotherapy Effective for Preschoolers
Majority of children reach tolerance great enough to protect them from accidental exposure to peanuts
Genetic Ancestry Tied to Lung Cancer Mutations in Latin Americans
Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
NHLBI Updates Guidance for Management of Asthma
Guidance focuses on tailored treatment interventions for specific age groups based on disease severity
Dexamethasone May Hinder Immunotherapy for Glioblastoma
Findings seen in preclinical studies of mice, survival data from patients receiving PD-(L)1 blockade for GBM
AI Model May Predict Immunotherapy Response in Melanoma
Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma
